The combination of Herceptin, Perjeta, and endocrine therapy without chemotherapy showed promising results in patients with HR+/HER2+ metastatic breast cancer. Adding Kisqali to the treatment regimen ...

Herceptin is a prescription drug used to treat certain kinds of breast and stomach cancer in adults. Learn about side effects and what to do about them.

Find out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and more.

"Resistance to Herceptin frequently occurs and currently represents a major clinical challenge for successful treatment of HER2-positive breast cancer," notes Dr. Liu. "Data presented in the study ...

The encouraging news is that treatment with Herceptin can be very effective, so much so that the advent of the drug has dramatically changed the prognoses for patients with this type of breast cancer.

Basel, 23 December 2020– Roche today announced that the European Commission has approved Phesgo ®, a fixed-dose combination of Perjeta ® and Herceptin ® with hyaluronidase, administered by ...

The encouraging news is that treatment with Herceptin can be very effective, so much so that the advent of the drug has dramatically changed the prognoses for patients with this type of breast cancer.

Dear Readers: Herceptin is the brand name for a drug called trastuzumab. It’s a targeted therapy that’s often used in conjunction with chemotherapy to treat a certain type of breast cancer ...

The encouraging news is that treatment with Herceptin can be very effective, so much so that the advent of the drug has dramatically changed the prognoses for patients with this type of breast cancer.

The encouraging news is treatment with Herceptin can be very effective, so much so the advent of the drug has dramatically changed the prognoses for patients with this type of breast cancer.

Herceptin is used to treat HER2 positive breast cancer, but side effects include heart damage. A new study finds that treating women with chemotherapy before or while giving Herceptin reduces damage.